Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide

EU orphan designation number: EU/3/15/1565   
Active ingredient: 2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide
Indication: Treatment of hepatocellular carcinoma
Sponsor: PBS Regulatory Consulting Group Limited
5 E. Vows Walk, Kirkcaldy, KY1 1SQ Fife, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/10/2015 Orphan designation EMA/OD/118/15 (2015)7036 of 9/10/2015